The production of generic drugs after the expiry of patents : which reality in Algeria?

الملخص EN

This article studies the impact of the expiry of patents on the production of generic drugs in Algeria.

For each molecule selected, we identified the number of locally made generic versions (NGFL), the age of the molecule (Mkt Age) and the number of years since the patent expires (Yrs Off).

Then, our contribution takes place in the form of an econometric modeling from panel data for the period 2006 to 2011.

We found that (Mkt Age) and (Yrs Off) have no impact on (NGFL).

Thus, we conclude that the algerien pharmaceutical industry does not take advantage of expired patents to develop its local production of generic drugs.